摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2-(4-甲氧基苯基)乙炔基)萘 | 1154405-70-5

中文名称
1-(2-(4-甲氧基苯基)乙炔基)萘
中文别名
——
英文名称
1-((4-methoxyphenyl)ethynyl)naphthalene
英文别名
1-[2-(4-Methoxyphenyl)ethynyl]naphthalene
1-(2-(4-甲氧基苯基)乙炔基)萘化学式
CAS
1154405-70-5
化学式
C19H14O
mdl
——
分子量
258.32
InChiKey
YCDZANXQZZABGP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    60-62 °C
  • 沸点:
    433.3±28.0 °C(Predicted)
  • 密度:
    1.16±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    5.2
  • 重原子数:
    20
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.05
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(2-(4-甲氧基苯基)乙炔基)萘selenium 作用下, 以 N-甲基吡咯烷酮 为溶剂, 反应 48.0h, 以46%的产率得到2-(4-methoxyphenyl)naphtho[2,1-b]selenophene
    参考文献:
    名称:
    通过芳乙炔基取代的多环芳烃的位点选择性硒环化多环芳烃稠合硒酚
    摘要:
    芳基乙炔基取代的多环芳烃使用硒粉在回流N-甲基-2-吡咯烷酮 (NMP) 中,借助 NMP 中残留的水作为催化质子源,通过氧化还原中性过程合成芳烃稠合硒酚。这种硒环化的位点选择性性质产生反式-烯烃作为竞争产品,它取决于多环芳烃的 π 电子供体能力和与其相连的芳乙炔基的种类。进行 DFT 计算以了解硒酚形成反应中的位点选择性。与多环芳烃的芳炔取代基碳相邻的碳上的 HOMO 系数与底物的硒环化趋势相关。吸收和发射的波长和发射的量子产率随着多环单元(从萘到芘)中稠合苯环数量的增加而增加。
    DOI:
    10.1021/acs.joc.1c00689
  • 作为产物:
    描述:
    参考文献:
    名称:
    Synthesis of 1,2-disubstituted acetylenes via copper-catalyzed Suzuki coupling of organoboronic acids with 1,1-dibromo-1-alkenes
    摘要:
    An efficient synthesis of 1,2-disubstituted acetylenes has been described. Reactions of organoboronic acids with 1,1-dibromo-1-alkenes in the presence of a catalytic amount of Cul (10 mol %), 8-hydroxyquinoline (10 mol %), and using potassium phosphate as base in C2H5OH afforded the desired 1,2-disubstituted acetylenes in good to excellent yields. It is important to note that the formation of 1,3-diynes, which are derived from the homocoupling of 1,1-dibromo-1-alkenes, can be almost completely suppressed under these optimized conditions. (c) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2012.08.044
点击查看最新优质反应信息

文献信息

  • Palladium-Catalyzed Decarbonylative Sonogashira Coupling of Terminal Alkynes with Carboxylic Acids
    作者:Xinyi Li、Long Liu、Tianzeng Huang、Zhi Tang、Chunya Li、Wenhui Li、Tao Zhang、Zhaohui Li、Tieqiao Chen
    DOI:10.1021/acs.orglett.1c00768
    日期:2021.5.7
    decarbonylative Sonogashira coupling of terminal alkynes with carboxylic acids was achieved through palladium catalysis. This reaction did not use overstoichiometric oxidants, thus overcoming the homocoupling issue of terminal alkynes. Under the reaction conditions, a wide range of carboxylic acids including those bioactive ones could couple readily with various terminal alkynes, thus providing a relative general
    末端炔烃与羧酸的直接脱羰Sonogashira偶联是通过钯催化实现的。该反应没有使用化学计量过量的氧化剂,因此克服了末端炔烃的均偶联问题。在反应条件下,包括那些具有生物活性的羧酸在内的各种羧酸都可以很容易地与各种末端炔烃偶联,因此提供了一种相对通用的制备内部炔烃的方法。
  • Macrocyclic hepatitis C serine protease inhibitors
    申请人:Miao Zhenwei
    公开号:US20050153877A1
    公开(公告)日:2005-07-14
    The present invention relates to compounds of Formula I, II or Ill, or a pharmaceutically acceptable salt, ester, or prodrug, thereof: wherein W is a substituted or unsubstituted heterocyclic ring system. The compounds inhibit serine protease activity, particularly the activity of hepatitis c virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis c virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
    本发明涉及式I、II或III的化合物,或其药用可接受的盐、酯或前药: 其中W是取代或未取代的杂环环系。这些化合物抑制丝氨酸蛋白酶活性,尤其是丙型肝炎病毒(HCV)NS3-NS4A蛋白酶的活性。因此,本发明的化合物干扰丙型肝炎病毒的生命周期,并且还可用作抗病毒剂。本发明进一步涉及包含上述化合物的药物组合物,用于给患有HCV感染的对象进行给药。本发明还涉及通过给主体投药包含本发明化合物的药物组合物来治疗主体HCV感染的方法。
  • Cleavage of Carbon–Carbon Triple Bond: Direct Transformation of Alkynes to Nitriles
    作者:Noriko Okamoto、Minoru Ishikura、Reiko Yanada
    DOI:10.1021/ol401311h
    日期:2013.6.7
    A new cleavage reaction of carbon–carbon triple bonds proceeds efficiently with NIS and TMSN3, giving the corresponding nitriles in moderate to good yields.
    NIS和TMSN 3可以有效地进行碳-碳三键的新裂解反应,从而以中等至良好的产率获得相应的腈。
  • LiHMDS-Promoted Palladium-Catalyzed Sonogashira Cross-Coupling of Aryl Fluorides with Terminal Alkynes
    作者:Jingjing He、Kang Yang、Jianhong Zhao、Song Cao
    DOI:10.1021/acs.orglett.9b03815
    日期:2019.12.6
    A highly efficient Pd-catalyzed Sonogashira coupling of various aryl fluorides with terminal alkynes in the presence of LiHMDS was developed. Both unreactive electron-rich fluoroarenes and electron-poor fluoroarenes proceeded smoothly and afforded the corresponding internal alkynes in moderate to excellent yields.
    在LiHMDS的存在下,开发了各种芳基氟化物与末端炔烃的高效Pd催化Sonogashira偶联。未反应的富电子氟代芳烃和贫电子的氟代芳烃均能顺利进行,并以中等至极好的收率提供了相应的内部炔烃。
  • Highly Active Palladium Catalyst for the Sonogashira Coupling Reaction of Unreactive Aryl Chlorides
    作者:Dong-Hwan Lee、Young-Jun Kwon、Myung-Jong Jin
    DOI:10.1002/adsc.201100747
    日期:2011.11
    communication reports on the β-diketiminatophosphane palladium-catalyzed copper-free Sonogashira coupling of aryl chlorides with alkynes. A catalyst loading of 0.5 mol% is sufficient to achieve high performance under relatively mild reaction conditions. Furthermore, dialkynylbenzenes are efficiently prepared by one-pot double Sonogashira couplings of aryl dichlorides.
    该通讯报道了β-二酮亚氨基膦烷钯钯催化的芳基氯化物与炔烃的无铜Sonogashira偶联。0.5mol%的催化剂负载量足以在相对温和的反应条件下实现高性能。此外,通过一锅二芳基二氯化物的双Sonogashira偶联有效地制备二炔基苯。
查看更多